MARAVAI LIFESCIENCES HOLDINGS, INC. Cash Flow Statement
MRVI / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
MARAVAI LIFESCIENCES HOLDINGS, INC. used $58M in operating cash flow and negative free cash flow of $71M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$130.8M | -$144.8M | -$119.0M | $220.2M | $182.0M | $89.0M | -$4.5M |
| Depreciation & Amortization | - | - | - | - | - | $5.6M | $3.8M |
| Operating Cash Flow | -$57.6M | $7.5M | $126.2M | $536.0M | $368.6M | $152.2M | $24.1M |
| Capital Expenditures | $13.1M | $29.7M | $65.6M | $17.1M | $14.8M | $25.4M | $17.1M |
| Free Cash Flow | -$70.7M | -$22.2M | $60.7M | $518.9M | $353.7M | $126.8M | $7.0M |
| Share Buybacks | - | - | - | $0 | $0 | $33.7M | $0 |
| FCF Margin | -38.1% | -8.6% | 21.0% | 58.8% | 44.3% | 44.6% | 4.9% |